Table 2:

Inferred treatment recommendations and confidence levels

Drug	Cancer subtype	Probability	Reference
Fluorouracil	HCC r/r	0.88	[16]
Dexamethasone	Bladder untreated	0.83	[17]
Carboplatin	Sarcoma untreated	0.79	[18]
Cisplatin	Sarcoma untreated	0.79	[19]
Gemcitabine	Sarcoma untreated	0.79	[20]
Folinic acid	HCC r/r	0.74	[21]
Temozolomide	CML untreated	0.72
Methotrexate	APL r/r	0.70	[22]
Cytarabine	T-NHL untreated	0.70	[23]
Cytarabine	CML r/r	0.70	[24]